In collaborazione con i centri di ricerca sul cancro, gli ospedali e il settore delle scienze della vita, siamo impegnati nell’empowerment dei pazienti (partecipazione e codecisione nel settore sanitario) e nella raccolta di dati a livello di studi regolatori. I sintomi registrati dai pazienti in combinazione con i dati clinici aprono nuove prospettive e opportunità per l’assistenza medica e la ricerca (prove reali).
Ciò consentirà lo sviluppo di nuovi metodi mirati per il trattamento del cancro e delle malattie.
Sostenete la ricerca sul cancro condividendo i vostri dati nell’app in forma pseudonimizzata. In questo modo, contribuite a migliorare le cure con la vostra esperienza di pazienti, naturalmente su base volontaria.
Sostenete la ricerca sul cancro aiutando i vostri pazienti a utilizzare l’applicazione e partecipando a studi e registri di eHealth.
Avviare insieme nuovi approcci di ricerca: avete un’idea? Abbiamo gli strumenti, i contatti e l’esperienza necessari.
CE-Mark Class I (MDD Class I)
Enables symptom progression tracking and CTCAE-based notifications to patients and oncologists.
Randomized trial in 140 breast cancer patients undergoing chemotherapy
📰 Published in JMIR 2016
Symptom recording in 150 patients undergoing immunotherapy
✔️ Accepted for publication in Current Oncology
(Topic: machine learning on ePROs to cluster symptoms by cancer type)
Case report in lung cancer: shared reporting improves comfort and efficiency
📰 Case Reports in Oncology, 2020
Digital symptom recording enhances patient-doctor interaction in 192 cancer patients
📰 JMIR Cancer, 2021
Durable response and tolerability in breast cancer therapy
📰 Case Reports in Oncology, 2021
Collaborative monitoring in 224 cancer patients
📰 JMIR, 2021
Real-world ePRO observational trial – 80 patients, 8 centers
📰 Published in JMIR Cancer (2024)
🔗 Article
Prospective randomized controlled study – 150 patients, 6 centers
Registry now maintained under Swiss sponsorship
Observational study on emergency-related symptom tracking and cost reduction
🔗 ClinicalTrials.gov: NCT06655337
Multicenter randomized controlled trial with 520 patients, 40 centers (Germany & Switzerland)
🧪 Ongoing trial
Ethics Approval: KEK-2022-D0021
Andreas holds a position as senior oncologist at both, the Brust- and the OnkoZentrum Zürich in Switzerland. Moreover, he is a titular-professor at the medical faculty of the University of Zurich. Treating cancer patients over more than 20 years clearly indicated that the consideration of PROs is key for treatment success. Driven by this conviction Andreas founded Mobile Health AG and started to develop Consilium Care™, an App for patients to capture well-being and therapy side effects. The current large observational study, started in 2018, investigates the efficiency of the “Consilium Care™” smartphone App for detecting symptoms and treatment side effects in cancer patients depending on form of medication application, age and outpatient characteristics.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Prof. Dr. med. Andreas Trojan
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Cookie | Durata | Descrizione |
---|---|---|
pll_language | 1 year | The pll _language cookie is used by Polylang to remember the language selected by the user when returning to the website, and also to get the language information when not available in another way. |
Cookie | Durata | Descrizione |
---|---|---|
cookielawinfo-checkbox-advertisement | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category . |
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
CookieLawInfoConsent | 1 year | Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie. |
elementor | never | This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time. |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Automated page speed optimizations for fast site performance